LUNG

PULMONX CORPORATION

LUNG · CIK 1127537 · Annual (10-K) · Last 5 years

Financial Trends

Revenue$84M
20202024
Net Income−$56M
20202024
Operating CF−$32M
20202024
Free Cash Flow−$33M
20202024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.1B$0.1B$0.1B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit$0.1B$0.1B$0.0B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.1B$0.1B$0.1B$0.1B$0.0B
Operating Income$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
Net Income$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
EPS (Basic)$-1.44$-1.60$-1.59$-1.35—
EPS (Diluted)$-1.44$-1.60$-1.59$-1.35—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.2B$0.2B$0.2B$0.2B$0.3B
Current Assets$0.1B$0.2B$0.2B$0.2B$0.2B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.2B
Total Liabilities$0.1B$0.1B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.2B$0.2B$0.2B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$-0.0B$-0.0B$-0.0B$0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.2B
← Companies